Male Sex Is Associated With Worse Microbiological and Clinical Outcomes Following Tuberculosis Treatment: A Retrospective Cohort Study, a Systematic Review of the Literature, and Meta-analysis
Authors:
Open Access
- 8 June 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 73 (9) , 1580-1588
Abstract
Background: Although the incidence of tuberculosis is higher in men than in women, the relationship of sex with tuberculosis treatment outcomes has not been adequately studied. Methods: We performed a retrospective cohort study and a systematic review and meta-analysis of observational studies during the last 10 years to assess sex differences in clinical and microbiological outcomes in tuberculosis. Results: In our cohort of 2894 Taiwanese patients with drug-susceptible pulmonary tuberculosis (1975 male and 919 female), male patients had higher adjusted hazards of 9-month mortality due to all causes (hazard ratio, 1.43 [95% confidence interval (CI), 1.03–1.98]) and infections (1.70 [1.09–2.64]) and higher adjusted odds of 2-month sputum culture positivity (odds ratio [OR], 1.56 [95% CI, 1.05–2.33]) compared with female patients. Smear positivity at 2 months did not differ significantly (OR, 1.27 [95% CI, .71–2.27]) between the sexes. Among 7896 articles retrieved, 398 were included in our systematic review describing a total of 3 957 216 patients. The odds of all-cause mortality were higher in men than in women in the pooled unadjusted (OR, 1.26 [95% CI, 1.19–1.34]) and adjusted (1.31 [1.18–1.45]) analyses. Men had higher pooled odds of sputum culture (OR, 1.44 [95% CI, 1.14–1.81]) and sputum smear (1.58 [1.41–1.77]) positivity, both at the end of the intensive phase and on completion of treatment. Conclusions: Our retrospective cohort showed that male patients with tuberculosis have higher 9-month all-cause and infection-related mortality, with higher 2-month sputum culture positivity after adjustment for confounding factors. In our meta-analysis, male patients showed higher all-cause and tuberculosis-related mortality and higher sputum culture and smear positivity rates during and after tuberculosis treatment.Keywords
All Related Versions
Funding Information
- National Institute of Allergy and Infectious Diseases
- National Institutes of Health (UH3AI122309, K24AI143447)
- Taiwan Centers for Disease Control (MOHW-105-CDC-C-114-000103)
This publication has 45 references indexed in Scilit:
- Treatment Outcomes for Extensively Drug-Resistant Tuberculosis and HIV Co-infectionEmerging Infectious Diseases, 2013
- mTOR regulation of autophagyFEBS Letters, 2010
- Sexual Inequality in TuberculosisPLOS Medicine, 2009
- The X-files in immunity: sex-based differences predispose immune responsesNature Reviews Immunology, 2008
- Testosterone Reduces Macrophage Expression in the Mouse of Toll-Like Receptor 4, a Trigger for Inflammation and Innate ImmunityBiology of Reproduction, 2008
- A systematic review of delay in the diagnosis and treatment of tuberculosisBMC Public Health, 2008
- Gender differentials of pulmonary tuberculosis transmission and reactivation in an endemic areaThorax, 2006
- Sex hormones and the immune response in humansHuman Reproduction Update, 2005
- Gender and tuberculosis controlHealth Policy, 2000
- Acute Phase Markers Are Associated with Reduced Plasma Lipid Levels in a Population of Hospitalized Elderly PatientsGerontology, 1999